SCHEMBL4138229

SCHEMBL4138229

CN(C)CCOc1ccc(-c2ccccn2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.69
CYP1A2 P05177 2/20 0.69
CYP19A1 P11511 1/20 0.69
CYP2C9 P11712 1/20 0.69
CYP2C19 P33261 1/20 0.69
ACVR1B P36896 1/20 0.62
TGFBR1 P36897 1/20 0.62
LTA4H P09960 2/20 0.57
LSS P48449 1/20 0.55
ACHE P22303 1/20 0.52
CXCR1 P25024 1/20 0.50
HRH3 Q9Y5N1 1/20 0.50
CHRNB2 P17787 1/20 0.50
CHRNA4 P43681 1/20 0.50
ESR1 P03372 2/20 0.49
MAPT P10636 2/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
NPC1 O15118 1/20 0.49
NR1I2 O75469 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29743819 0.83 CHRNB2 (0.56) CYP2D6CYP1A2CYP19A1CYP2C9CYP2C19
SCHEMBL20653365 0.83 CHRNB2 (0.56) CYP2D6CYP1A2CYP19A1CYP2C9CYP2C19
SCHEMBL23252299 0.82 CYP2D6 (1.00) CYP2D6CYP1A2CYP19A1CYP2C9CYP2C19
SCHEMBL23405947 0.81 CHRNB2 (0.54) CYP2D6CYP1A2CYP19A1CYP2C9CYP2C19
SCHEMBL29743809 0.81 CHRNB2 (0.54) CYP2D6CYP1A2CYP19A1CYP2C9CYP2C19
SCHEMBL29743873 0.81 ACVR1B (0.58) CYP2D6CYP1A2CYP19A1CYP2C9CYP2C19
SCHEMBL20641478 0.81 ACVR1B (0.58) CYP2D6CYP1A2CYP19A1CYP2C9CYP2C19
SCHEMBL20641506 0.80 ACVR1B (0.46) CYP2D6CYP1A2CYP19A1CYP2C9CYP2C19
SCHEMBL22831331 0.80 LSS (0.83) CYP2D6CYP1A2LTA4HLSSACHE
SCHEMBL410420 0.79 TGFBR1 (0.67) CYP2D6CYP1A2CYP19A1CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054467-A1 Pyrrolo Pyrimidines as Agents for the Inhibition of Cystein Proteases BETSCHART CLAUDIA 2009-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054467-A1 Pyrrolo Pyrimidines as Agents for the Inhibition of Cystein Proteases CTSK, CTSS, CTSZ CYP2D6 2419/4885CYP1A2 3724/4885CYP19A1 1054/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.